What is HAE's gross margin?

Haemonetics (HAE) has a gross margin of 56% and a net margin of 12%.

What is HAE's P/E ratio?

HAE's P/E ratio is 31.0 with ROE of 19%.

Where can I see HAE's full financials?

See Haemonetics (HAE) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Haemonetics (HAE) Financials — Revenue, Earnings, Cash Flow

$65.49

+3.55 (+5.73%)

After Hours: $63.92 (-1.56, -2.39%)

Weekly Expected Move ±6.8%

$49 $52 $56 $60 $64

NYSE · Healthcare · Medical - Instruments & Supplies · Alpha Radar Buy · Power 64 · $3.0B mcap · 45M float · 1.75% daily turnover · Short 65% of daily vol

📊 Key Metrics

TTM

$1B

Revenue

-2.5% YoY

$168M

Net Income

+35.8% YoY

$256M

Free Cash Flow

+462.5% YoY

56.0%

Gross Margin

20.6%

Op. Margin

11.8%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE18.9%

ROA7.2%

ROIC10.3%

Valuation

P/E31.0

P/B3.8

EV/EBITDA8.8

Leverage

Debt/Equity1.49

Current Ratio1.62

Interest Cov.12.2x

Quality Scores

Piotroski F7/9

Altman Z2.10

Beneish M-2.68